Eucrates Biomedical Acquisition Corp.
EUCR · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|
| Operating Activities | – | – | – |
| Net Income | $2,420 | $3,824 | – |
| Dep. & Amort. | $0 | $0 | – |
| Deferred Tax | $0 | $0 | – |
| Stock-Based Comp. | $0 | $0 | – |
| Change in WC | $68 | $241 | – |
| Other Non-Cash | -$3,118 | -$4,567 | – |
| Operating Cash Flow | -$630 | -$502 | – |
| Investing Activities | – | – | – |
| PP&E Inv. | $0 | $0 | – |
| Net Acquisitions | $0 | $0 | – |
| Inv. Purchases | $0 | $0 | – |
| Inv. Sales/Matur. | $0 | $0 | – |
| Other Inv. Act. | $93,191 | $0 | – |
| Investing Cash Flow | $93,191 | $0 | – |
| Financing Activities | – | – | – |
| Debt Repay. | $0 | $0 | – |
| Stock Issued | $0 | $0 | – |
| Stock Repurch. | -$93,191 | $0 | – |
| Dividends Paid | $0 | $0 | – |
| Other Fin. Act. | -$92,591 | $0 | – |
| Financing Cash Flow | -$92,591 | $0 | – |
| Forex Effect | $0 | $0 | – |
| Net Chg. in Cash | -$30 | -$502 | – |
| Supplemental Information | – | – | – |
| Beg. Cash | $49 | $551 | – |
| End Cash | $19 | $49 | – |
| Free Cash Flow | -$630 | -$502 | – |